Androulla Eleftheriou
Executive Director, Thalassemia International Federation (TIF), Nicosia, Cyprus
Dr. Androulla Eleftheriou, born in Cyprus, holds a BSc, MSc, and PhD in Biochemistry, Microbiology, and Virology from London Universities. She has been awarded numerous scholarships by the Cyprus government, the World Health Organization (WHO), and the Fulbright Commission. She completed her postdoctoral fellowship at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA, USA.
From 1990 to August 2006, Dr. Eleftheriou served as Head of the Virus Reference Centre at the Cyprus Ministry of Health (Public Health). Since 2005, she has been the Director of the Cyprus WHO Thalassaemia/Haemoglobin Disorders/Rare Anaemias Collaborating Centre. She has worked closely with the Thalassaemia International Federation (TIF) since 1993, initially as a Scientific Coordinator for TIF’s educational programs on a voluntary basis. In 2006, she officially assumed the role of Executive Director of the Federation upon proposal from TIF’s Board of Directors. She continues to regularly act as a WHO consultant on issues related to her field of expertise.
Through her work with TIF, Dr. Eleftheriou collaborates and works closely with the World Health Organization, the European Commission, various Regional and International bodies, scientific and medical associations, academia, and the research community. Through her leadership at TIF, she has spearheaded many joint initiatives with official health-related organisations and agencies, national and regional health authorities and numerous disease and non-disease specific patient/parents organisations.
Dr. Eleftheriou has served through the years on the Board of the International Alliance of Patients’ Organizations (IAPO) and the European Public Health Alliance (EPHA) and has been an Advisory Board member of the European School of Transfusion Medicine (ESTM). Additionally, she participated in the European Union Committee of Experts in Rare Diseases (EUCERD) and other projects. Since 2016, she has chaired the Higher Scientific Committee of the Sultan Bin Khalifa International Thalassemia Award (SITA), and in 2022, she was appointed President of the National Thalassaemia Committee under the Cyprus Ministry of Health.
Dr. Eleftheriou was instrumental in the creation of the Cyprus Alliance for Rare Disorders (CARD) and had a key role in its development for 11 years, including the post of the President. She also held the position of Vice-Chair of the European Hematology Association (EHA) Patient Advocacy Committee for two years. Her contributions to the field include authorship of numerous peer-reviewed journal articles, position papers, books, booklets, fact sheets, and e-learning programs over the past two decades.
Her work has been recognized with several prestigious awards, including the Panos Englezos Award (2003) for her contribution to the promotion of TIF’s mission and activities, the HemaSphere Award (2024) from EHA for the study “2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassaemia”, and multiple other accolades from various countries around the world. She also received a Certification in Capacity Building from Harvard University (2010).